Crainio Non-invasive ICP Monitor for TBI
Crainio Non-invasive Intracranial Pressure Monitor for Traumatic Brain Injury: Product Development
1 other identifier
interventional
54
1 country
1
Brief Summary
The clinical investigation aims to advance the Crainio device, designed for non-invasive intracranial pressure (ICP) monitoring. This feasibility study involves 54 participants over a 12-month period and seeks to collect cerebral photoplethysmogram signals alongside concurrent invasive ICP measurements in patients with traumatic brain injury. The primary objective is to establish the diagnostic accuracy of the Crainio device, aiming for at least 90% sensitivity and specificity in detecting raised ICP (above 20 mmHg). Secondary objectives include evaluating patient-related factors such as skin tone, skull thickness, and skull density, as well as the tolerability and acceptance of the device by both patients and healthcare professionals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 30, 2024
CompletedFirst Posted
Study publicly available on registry
June 12, 2024
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
March 18, 2026
March 1, 2026
1 year
May 30, 2024
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sensitivity
Generate a nICP model offline with a sensitivity above 90% to discriminate ICP values over 20 mmHg.
12 hours record per patient
Specificity
Generate a nICP model offline with a specificity above 90% to discriminateICP values over 20 mmHg.
12 hours record per patient
Secondary Outcomes (5)
Skin tone through Fitzpatrick scale
1 classification per patient (3 minutes)
Skull thickness through CT scan
1 measurement per patient (3 minutes)
Skull density through Age stratification analysis
1 classification per patient (1 minute)
Device usability
1 form per patient (5 minutes)
Advers effects and events
12 hours record per patient
Study Arms (1)
Crainio
EXPERIMENTALAcquisition of cerebral PPG signals from Crainio's probe stuck to the patient's forehead, alongside concurrent invasive ICP measurements in patients with traumatic brain injury
Interventions
Crainio device comprises a forehead-mounted sensor containing infrared light sources that can illuminate the deep brain tissue of the frontal lobe. Photodetectors in the sensor detect the backscattered light, which is modulated by pulsation of the cerebral arteries. A control unit processes the backscattered light (called the photoplethysmogram, PPG) and transmits it to a computer device to train ML models that will estimate ICP offline.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of traumatic brain injury.
- Adults (aged between 16 and 99, male and female)
- TBI patients admitted to the Royal London Hospital.
- Patients having invasive ICP monitoring as part of their normal medical treatment.
You may not qualify if:
- Forehead skin is not intact.
- Decompressive craniectomy patients.
- Open external ventricular drainage (EVD) treatment.
- Patients who will unlikely survive the following twelve hours.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Crainio Ltdalead
- Innovate UKcollaborator
- Barts & The London NHS Trustcollaborator
- City, University of Londoncollaborator
Study Sites (1)
Royal London Hospital
London, England, E1 1BB, United Kingdom
Related Publications (9)
Roldan M, Kyriacou PA. Near-Infrared Spectroscopy (NIRS) in Traumatic Brain Injury (TBI). Sensors (Basel). 2021 Feb 24;21(5):1586. doi: 10.3390/s21051586.
PMID: 33668311BACKGROUNDRoldan M, Abay TY, Kyriacou PA. Non-Invasive Techniques for Multimodal Monitoring in Traumatic Brain Injury: Systematic Review and Meta-Analysis. J Neurotrauma. 2020 Dec 1;37(23):2445-2453. doi: 10.1089/neu.2020.7266. Epub 2020 Sep 24.
PMID: 32821023BACKGROUNDRoldan M, Chatterjee S, Kyriacou PA. Brain Light-Tissue Interaction Modelling: Towards a non-invasive sensor for Traumatic Brain Injury. Annu Int Conf IEEE Eng Med Biol Soc. 2021 Nov;2021:1292-1296. doi: 10.1109/EMBC46164.2021.9630909.
PMID: 34891522BACKGROUNDRoldan M, Kyriacou PA. Head Phantom Optical Properties Validation for Near-Infrared Measurements: A Comparison with Animal Tissue. Annu Int Conf IEEE Eng Med Biol Soc. 2022 Jul;2022:641-644. doi: 10.1109/EMBC48229.2022.9871103.
PMID: 36085774BACKGROUNDRoldan M, Bradley GRE, Mejia-Mejia E, Abay TY, Kyriacou PA. Non-invasive monitoring of intracranial pressure changes: healthy volunteers study. Front Physiol. 2023 Aug 8;14:1208010. doi: 10.3389/fphys.2023.1208010. eCollection 2023.
PMID: 37614754BACKGROUNDRoldan M, Abay TY, Uff C, Kyriacou PA. A pilot clinical study to estimate intracranial pressure utilising cerebral photoplethysmograms in traumatic brain injury patients. Acta Neurochir (Wien). 2024 Feb 27;166(1):109. doi: 10.1007/s00701-024-06002-4.
PMID: 38409283BACKGROUNDM. Roldan and P. A. Kyriacou, Head Phantom for the Acquisition of Pulsatile Optical Signals for Traumatic Brain Injury Monitoring, Photonics, vol. 10, no. 5, 2023
BACKGROUNDT. Y. Abay, J. P. Phillips, C. Uff, M. Roldan, and P. A. Kyriacou, In Vitro Evaluation of a Non-Invasive Photoplethysmography Based Intracranial Pressure Sensor, Appl. Sci., vol. 13, no. 1, p. 534, Dec. 2022
BACKGROUNDM. Roldan and P. A. Kyriacou, "A non-Invasive Optical Multimodal Photoplethysmography-Near Infrared Spectroscopy Sensor for Measuring Intracranial Pressure and Cerebral Oxygenation in Traumatic Brain Injury," Appl. Sci., 2023
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chris Uff, Dr
Barts & The London NHS Trust
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 30, 2024
First Posted
June 12, 2024
Study Start
May 15, 2025
Primary Completion (Estimated)
May 15, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
March 18, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Only the final results of Crainio device diagnostic accuracy and safety would be published. Any individual participant data would be available to other researchers.